# Southeast Xlerator Network

> **NIH NIH UT2** · XLERATEHEALTH, LLC · 2020 · $1,460,435

## Abstract

The Southeast XLerator Network proposes to create a networked and easily accessible regional
technology transfer accelerator hub (“XLerator Hub” or “Hub”) to share best practices,
disseminate education content, and offer products, services, facilities and other resources
connected through both physical and online platforms for innovators and trainees in the Southeast
IDeA states. Led by XLerateHealth, LLC, an SBA award-winning healthcare-focused technology
accelerator, the Hub will 1) bridge the divide between great ideas and the marketplace by
leveraging and connecting existing resources and unique expertise assets across all participating
entities in the Southeast IDeA state region, 2) fill the gaps that constitute barriers to efficient
commercialization among partner institutions, and 3) deliver the necessary resources, education,
and business networks to foster and sustain a culture of entrepreneurship across the region. This
project will address significant disparities and lack of access to resources, talent and capital in
respective local commercialization ecosystems for biomedical technologies that are pervasive
across the Southeast IDeA state region, making the rates of technology transfer and
commercialization of academic research discoveries in this region suboptimal. The Hub
objectives/ core functions are:
 1. To improve knowledge and understanding by innovators about how technologies are
 brought to market.
 2. To improve knowledge and understanding by accelerators and technology transfer offices
 about the unique commercialization pathways of various biomedical technologies
 3. To facilitate access to technology/product development and commercialization resources
 required for early-stage technology advancement and later-stage product development
 4. To help close the gap(s) in funding (a) between basic research discoveries and scientific
 proof of feasibility, and (b) between exhaustion of grant funding and private capital
 required to generate products and revenues.
 5. To commercialize new innovation in pharmaceuticals, medical devices, healthcare IT and
 electronics, and other biomedical technologies through entrepreneurship, licensing and
 partnerships with established companies, and additionally commercialize the Hub’s
 platform, programs, and materials through access by other regions.
The impact of the Hub will be increased market-ready technologies and patents, more successful
startups, and increased biomedical technology acceleration.

## Key facts

- **NIH application ID:** 10004685
- **Project number:** 5UT2GM130174-03
- **Recipient organization:** XLERATEHEALTH, LLC
- **Principal Investigator:** Eugene Krentsel
- **Activity code:** UT2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,460,435
- **Award type:** 5
- **Project period:** 2018-09-01 → 2022-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10004685

## Citation

> US National Institutes of Health, RePORTER application 10004685, Southeast Xlerator Network (5UT2GM130174-03). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10004685. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*